Increasing compliance and regulatory requirements, security initiatives, demand for superior customer service, price pressures—these are the challenges faced by banking and financial institutions globally.

Leading retail and wholesale banks, card services, lending firms, investment banks, financial institutions, securities traders and brokerage firms have partnered with RevereIT to optimize their software applications & platforms, enhance operational efficiencies, minimize risks and sustain cost leadership.

RevereIT helps Banking & Financial Services firms transform business processes, rationalize product portfolios, modernize operations into a cost-effective, strategize business assets, comply with regulations, managing risks and maximize customer satisfaction. Our Platforming methodology, blended with Global Delivery Model and proven processes build comprehensive IT solutions that help financial institutions address business needs, in order to achieve positive and measurable return-on-investment.

RevereIT’s Business Process Management (BPM) and Service-Oriented Architecture (SOA) expertise helps provide a consistent enterprise view, facilitates transformation, brings best practice workflows and increases overall operational efficiency. RevereIT’s deep domain knowledge, experience in Banking & Financial Services and technology realm while working with Fortune 500 financial institutions and industry-leading software vendors provides unique advantage to cross-leverage skills and best practices.

RevereIT also works with leading software companies in the areas of BPM, cash management, online customer self-service, enterprise content management, and banking and payment technologies, providing the entire range of services from product conceptualization to implementation right through to customer implementation and support.

Computer Systems Validation

Computer System Validation (CSV) in regulated operations provides confirmation by examination and provision of objective evidence.

Validation for Vaccine Manufacturers An Introduction

This guidance document has been prepared to aid vaccine manufacturers in the preparation and performance of the validation studies required by GMP.